Onchocerciasis in West Africa after 2002: a challenge to take up

Onchocerciasis in West Africa after 2002: a challenge to take up

Initially planned for a 20 year life time, the Onchocerciasis Control Programme in West Africa (OCP) will have finally continued its activities for nearly three decades (vector control alone from 1975 to 1989, then vector control and/or therapeutic treatment until 2002). Although onchocerciasis is n...

Full description

Bibliographic Details
Main Authors:	Hougard J.M., Yameogo L., Philippon B.
Format:	Article
Language:	English
Published:	EDP Sciences 2002-06-01
Series:	Parasite
Subjects:	onchocerciasis insecticides ivermectin West Africa post OCP period
Online Access:	http://dx.doi.org/10.1051/parasite/2002092105

Similar Items

Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective
by: Ed Cupp, et al.
Published: (2019-07-01)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al.

Important progress towards elimination of onchocerciasis in the West Region of Cameroon
by: Guy-Roger Kamga, et al.
Published: (2017-08-01)

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
by: Mary Amuyunzu-Nyamongo, et al.
Published: (2011-05-01)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: Winnen M., et al.
Published: (2002-01-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
by: E N Shu, et al.
Published: (2004-01-01)

The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs
by: Frank O. Richards, et al.
Published: (2019-07-01)

Onchocerciasis then and now: achievements, priorities and challenges
by: Adrian Hopkins
Published: (2018-01-01)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
by: Robert Colebunders, et al.
Published: (2019-10-01)

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
by: Wilma A. Stolk, et al.
Published: (2015-10-01)

Epidemiological evaluation of onchocerciasis along Ogun River System, southwest Nigeria
by: S.O. Sam-Wobo , M.A. Adeleke , O.A. Jayeola , A.O. Adeyi , A.S. Oluwole , M. Ikenga , A. Lawniye , J. Gazama , A. Kagni , T.O. Kosoko , O. Agbeyangi , S. Bankole , L. Toé , C.F. Mafiana & L. Yameogo
Published: (2012-06-01)

Ivermectin therapy for onchocerciasis: Effect on some haematological and biochemical parameters
by: E N Shu, et al.
Published: (2008-01-01)

The need for evidence-based strategies and tools for onchocerciasis elimination in Africa
by: Yankum Dadzie, et al.
Published: (2019-07-01)

The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data
by: Hugo C Turner, et al.
Published: (2015-03-01)

Onchocerciasis Elimination: Progress and Challenges
by: Lakwo T, et al.
Published: (2020-10-01)

Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia
by: Adugna Endale, et al.
Published: (2015-02-01)

Determinants of community-led ivermectin treatment adherence for onchocerciasis control in Western Ethiopia: a case-control study
by: Fikadu Ayalew, et al.
Published: (2020-04-01)

Presumed Onchocerciasis Chorioretinitis Spilling over into North America, Europe and Middle East
by: Ahmad Mansour, et al.
Published: (2023-12-01)

Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes
by: Yankum Dadzie, et al.
Published: (2018-07-01)

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
by: Michel Mandro, et al.
Published: (2020-03-01)

Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
by: Robert Colebunders, et al.
Published: (2024-01-01)

Review of the National Program for Onchocerciasis Control in the Democratic Republic of the Congo
by: Jean-Claude Makenga Bof, et al.
Published: (2019-06-01)

Onchocerciasis dynamics: modelling the effects of treatment, education and vector control
by: Asha Hassan, et al.
Published: (2020-01-01)

Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
by: Uwem F. Ekpo, et al.
Published: (2022-11-01)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
by: Alfred Dusabimana, et al.
Published: (2022-02-01)

Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment
by: Guy-Roger Kamga, et al.
Published: (2016-11-01)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
by: Robert Colebunders, et al.
Published: (2022-03-01)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-08-01)

The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door-to-Door Survey
by: Stephen Raimon Jada, et al.
Published: (2022-03-01)

Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon
by: Guy-Roger Kamga, et al.
Published: (2018-06-01)

Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa
by: Gebremedhin Gebrezgabiher, et al.
Published: (2019-07-01)

Entomological assessment of the transmission following recrudescence of onchocerciasis in the Comoé Valley, Burkina Faso
by: Lassane Koala, et al.
Published: (2019-01-01)

Ivermectin Treatment Coverage Validation in Two Onchocerciasis Endemic Districts in Ethiopia: A Community-Based Cross-Sectional Study, 2019
by: Churko C, et al.
Published: (2021-01-01)

Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually
by: Jérémy T. Campillo, et al.
Published: (2020-05-01)

Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach
by: Carabin Hélène, et al.
Published: (2003-01-01)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
by: Alfred Dusabimana, et al.
Published: (2020-10-01)

Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment
by: Samuel Wanji, et al.
Published: (2015-04-01)

Integration of onchocerciasis morbidity management and disability prevention services in the healthcare system in Tanzania: a call for action and recommendations
by: Vivian Mushi, et al.
Published: (2024-01-01)

Onchocerciasis: the beginning of the end?
by: Adrian Hopkins
Published: (2019-02-01)

Onchocerciasis control: biological research is still needed
by: Boussinesq M.
Published: (2008-09-01)